- Home
- RMAX vs ANIX Comparison
RMAX vs ANIX Comparison
Compare RMAX & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMAX | ANIX |
|---|---|---|
| Founded | 1973 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.9M | 135.3M |
| IPO Year | 2013 | 1987 |
Fundamental Metrics
Financial Performance| Metric | RMAX | ANIX |
|---|---|---|
| Price | $8.12 | $3.52 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $9.00 | $9.00 |
| AVG Volume (30 Days) | 148.0K | ★ 353.5K |
| Earning Date | 10-30-2025 | 01-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | ★ $292,931,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.90 | N/A |
| P/E Ratio | $13.73 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.90 | $2.07 |
| 52 Week High | $12.55 | $5.46 |
Technical Indicators
Market Signals| Indicator | RMAX | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 47.62 | 35.17 |
| Support Level | $7.98 | $4.20 |
| Resistance Level | $8.56 | $5.46 |
| Average True Range (ATR) | 0.21 | 0.42 |
| MACD | 0.04 | -0.12 |
| Stochastic Oscillator | 12.07 | 4.51 |
Price Performance
Historical ComparisonAbout RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.